Argatroban (Gland Pharma Limited)
Welcome to the PulseAid listing for the Argatroban drug offered from Gland Pharma Limited. This Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Gland Pharma Limited |
NON-PROPRIETARY NAME: | Argatroban |
SUBSTANCE NAME: | ARGATROBAN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-05-26 |
END MARKETING DATE: | 0000-00-00 |
Argatroban HUMAN PRESCRIPTION DRUG Details:
Item Description | Argatroban from Gland Pharma Limited |
LABELER NAME: | Gland Pharma Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 125(mg/125mL) |
START MARKETING DATE: | 2017-05-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68083-141_69efc0d6-1280-4920-b920-c56bfc353602 |
PRODUCT NDC: | 68083-141 |
APPLICATION NUMBER: | ANDA205570 |
Other ARGATROBAN Pharmaceutical Manufacturers / Labelers: